http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013035836-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_962794626a937783f7c684670eba23e7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_401c2a1bee0e6247413ea347c1670dae |
| publicationDate | 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013035836-A |
| titleOfInvention | P glycoprotein excretion inhibitor |
| abstract | An object of the present invention is to provide a P-glycoprotein excretion function inhibitor capable of suppressing a drug taken into a cell from being discharged out of the cell by active transport. An excretion function inhibitor of P-glycoprotein contains milnacipran as an active ingredient. Since the P-glycoprotein excretion function inhibitor of the present invention can suppress the excretion function of P-glycoprotein, the effect of the drug can be enhanced by using it together with an agent that is a substrate for P-glycoprotein. [Selection] Figure 7 |
| priorityDate | 2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.